Synergistic Effect of a Retinoid X Receptor-Selective Ligand Bexarotene and Docetaxel in Prostate Cancer [Corrigendum]
OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s235000
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2019
Authors
Publisher
Informa UK Limited